We are live on
!
Find out more
Lazard Asset Management Portfolio holdings
AUM
$60.8B
1-Year Est. Return
22.47%
This Fund
S&P 500
This Quarter
Est. Return
+5.89%
1 Year Est. Return
+22.47%
3 Year Est. Return
+62.53%
5 Year Est. Return
+77.87%
10 Year Est. Return
+302.07%
AUM
$47.8B
AUM Growth
+$3.07B
(+6.9%)
Cap. Flow
-$507M
Cap. Flow
% of AUM
-1.06%
Top 10 Holdings %
Top 10 Hldgs %
17.74%
Holding
1,131
New
130
Increased
292
Reduced
306
Closed
143
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teva Pharmaceuticals
TEVA
|
+$526M |
| 2 |
Ally Financial
ALLY
|
+$198M |
| 3 |
CSX Corp
CSX
|
+$191M |
| 4 |
NetEase
NTES
|
+$173M |
| 5 |
Norwegian Cruise Line
NCLH
|
+$171M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$262M |
| 2 |
CVS Health
CVS
|
+$240M |
| 3 |
Mastercard
MA
|
+$204M |
| 4 |
McKesson
MCK
|
+$201M |
| 5 |
Molson Coors Class B
TAP
|
+$171M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 14.83% |
| 2 | Communication Services | 13.94% |
| 3 | Technology | 12.15% |
| 4 | Financials | 10.5% |
| 5 | Energy | 9.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
251
Mativ Holdings
MATV
$482M
| $19.6M | 0.04% |
448,983
+31,840
| +8% | +$1.34M |
|
252
3D Systems Corp
DDD
$412M
| $19.3M | 0.04% |
321,940
| – | – |
|
253
TJX Companies
TJX
$178B
| $19.1M | 0.04% |
718,072
+18,574
| +3% | +$530K |
|
254
Sabesp
SBS
$19.4B
| $19M | 0.04% |
9,139,054
+3,411,184
| +60% | +$6.54M |
|
|
BCR
255
DELISTED
CR Bard Inc.
BCR
| $18.6M | 0.04% |
130,255
+106,136
| +440% | +$15.2M |
|
|
FLIR
256
DELISTED
FLIR Systems, Inc. (DE) Common Stock
FLIR
| $18.2M | 0.04% |
523,810
-208,085
| -28% | -$7.29M |
|
|
AL
257
DELISTED
Air Lease Corp
AL
| $18.1M | 0.04% |
469,565
+151,438
| +48% | +$5.8M |
|
258
American Electric Power
AEP
$72.4B
| $17.9M | 0.04% |
321,875
-46,015
| -13% | -$2.43M |
|
259
Tronox
TROX
$981M
| $17.9M | 0.04% |
+664,801
| New | +$17M |
|
|
TGI
260
DELISTED
Triumph Group
TGI
| $17.8M | 0.04% |
255,075
-10,140
| -4% | -$684K |
|
261
Archrock
AROC
$6.19B
| $17.7M | 0.04% |
394,044
+393,844
| +196,922% | +$17M |
|
262
Bank of America
BAC
$439B
| $17.6M | 0.04% |
1,144,017
-10,045,146
| -90% | -$156M |
|
|
APF
263
DELISTED
Morgan Stanley Asia Pacific Fund
APF
| $17.6M | 0.04% |
1,052,208
-587,547
| -36% | -$9.6M |
|
264
Allstate
ALL
$70.1B
| $17.6M | 0.04% |
299,165
-78,627
| -21% | -$4.53M |
|
|
KEF
265
DELISTED
Korea Equity Fund
KEF
| $17.5M | 0.04% |
1,981,179
-7,750
| -0.4% | -$66.4K |
|
266
Toro Company
TTC
$9.08B
| $17.4M | 0.04% |
546,786
-47,516
| -8% | -$1.52M |
|
267
Procter & Gamble
PG
$347B
| $17.3M | 0.04% |
220,632
+79,452
| +56% | +$6.41M |
|
268
Kilroy Realty
KRC
$4.5B
| $17.3M | 0.04% |
277,563
+6,385
| +2% | +$386K |
|
|
BYI
269
DELISTED
BALLY TECHNOLOGIES, INC.
BYI
| $17.2M | 0.04% |
262,313
-60,208
| -19% | -$3.76M |
|
|
CBL
270
DELISTED
CBL& Associates Properties, Inc.
CBL
| $17.1M | 0.04% |
898,475
+94,683
| +12% | +$1.75M |
|
271
Littelfuse
LFUS
$9.91B
| $17M | 0.04% |
183,096
+25,642
| +16% | +$2.35M |
|
272
Stagwell
STGW
$1.98B
| $16.9M | 0.04% |
788,700
+228,345
| +41% | +$5.12M |
|
|
CHS
273
DELISTED
Chicos FAS, Inc.
CHS
| $16.9M | 0.04% |
994,348
+129,446
| +15% | +$2.07M |
|
|
PBCT
274
DELISTED
People's United Financial Inc
PBCT
| $16.7M | 0.04% |
1,102,595
+159,166
| +17% | +$2.33M |
|
|
AIMC
275
DELISTED
Altra Industrial Motion Corp
AIMC
| $16.6M | 0.03% |
455,061
+87,507
| +24% | +$3.07M |
|
Similar funds
QCM
Lazard Asset Management's Q2 2014 Portfolio in Review
As of Q2 2014, Lazard Asset Management held 1,131 positions worth $47.8B, up 6.9% from $44.8B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Lazard Asset Management's Q2 2014 filing shows 130 new, 292 increased, 306 reduced and 143 closed positions. Its largest new stake was Ally Financial: 8,153,883 shares worth $195M. The largest sale was Gilead Sciences, an estimated $262M.
By sector, the portfolio is most concentrated in Healthcare at 15% of assets, down from 16% a quarter earlier, followed by Communication Services and Technology.
- Lazard Asset Management's largest Q2 2014 buy was Ally Financial: 8,153,883 shares worth $195M.
- Lazard Asset Management added most to Teva Pharmaceuticals in Q2 2014, an estimated $526M increase.
- Lazard Asset Management's biggest Q2 2014 reduction was Gilead Sciences, cutting an estimated $262M.
- Lazard Asset Management fully exited Mastercard in Q2 2014, selling an estimated $204M.
- Lazard Asset Management's ten largest holdings make up 18% of its $47.8B portfolio in Q2 2014.
- Lazard Asset Management opened 130 new positions and closed 143 in Q2 2014.
- Lazard Asset Management's portfolio value rose 6.9% quarter-over-quarter to $47.8B.
Based on Lazard Asset Management's 13F filing for Q2 2014, filed 12 Aug 2014.